Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Why BioNTech SE Was Surging Today
08:45pm, Monday, 25'th Apr 2022 The Motley Fool
The vaccine maker got a dose of good news late last week, and ongoing lockdowns in China perhaps spurred some optimism.
Novavax (NVAX) Starts COVID-19 Booster Study in Adolescents
05:24pm, Monday, 25'th Apr 2022 Zacks Investment Research
Novavax's (NVAX) begins administering a third/booster dose of its COVID-19 vaccine in adolescents aged between 12 years and 17 years in a pivotal late-stage study.
BME: Good Times, Bad Times, A Fund For All Times
04:50am, Sunday, 24'th Apr 2022 Seeking Alpha
BME focuses on an underlying portfolio of healthcare stocks with a covered call strategy. Click here to see BME's holdings, performance, and my recommendation.
Does This Vaccine-Maker's Upcoming Share Repurchase Make It a Buy?
02:07pm, Friday, 22'nd Apr 2022 The Motley Fool
It could be an important sign of a transitional period to come.
Could Pfizer Stock Help You Become a Millionaire?
01:05pm, Friday, 22'nd Apr 2022 The Motley Fool
The company is full of growth potential, plus it pays a top yield.
Novavax (NVAX) Posts Upbeat Data on COVID/Flu Combo Jab Study
03:58pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Results from Novavax's (NVAX) phase I/II study, which is evaluating a combination of its COVID-19 vaccine and the seasonal influenza vaccine candidate, demonstrate the combo vaccine's feasibility.
2 Charts Big Pharma Investors Need to Understand
03:45pm, Thursday, 21'st Apr 2022 The Motley Fool
The industry's leaders will fight to maintain their ranking over the next few years.
2 Monster Stocks to Buy Without Any Hesitation
03:37pm, Thursday, 21'st Apr 2022 The Motley Fool
These healthcare giants know something about beating the market.
Is It Too Late to Buy Novavax Stock?
10:30am, Thursday, 21'st Apr 2022 The Motley Fool
This biotech already soared more than 3,000% over the past two years.
Pfizer (PFE) Dips More Than Broader Markets: What You Should Know
09:45pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
In the latest trading session, Pfizer (PFE) closed at $49.75, marking a -0.86% move from the previous day.
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
02:52pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Missed Intuitive Surgical? Buy This Stock Instead
02:15pm, Wednesday, 20'th Apr 2022 The Motley Fool
Much as Intuitive Surgical redefined the surgical field, this company is updating how abnormal heart rhythms are diagnosed.
Moderna (MRNA) Posts Upbeat Data on Bivalent COVID Booster Jab
02:02pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Moderna's (MRNA) bivalent COVID booster candidate creates superior neutralizing antibodies compared to its currently authorized COVID vaccine mRNA-1273's booster dose against all variants of concern.
Moderna is developing a COVID-19 booster that protects against omicron and the original virus
12:05pm, Wednesday, 20'th Apr 2022 MarketWatch
The company said it expects to have clinical data for this shot by the end of June.
